longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

KAISA HEALTH

00876

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -1.73, above the reasonable range, cheaper than 4.6% of the time in the past 1 years, and the industry ranks 8/12, the industry Median 8.96.

-1.73xP/E
HK$1.65Stock price
HK$-0.96Earnings per share
-1.73xP/E
Stock priceHK$1.65Earnings per shareHK$-0.96

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-11.23x
Typical range
-15.51x–-4.17x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 8.96x
08162432

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 8.96x
0x10x20x30x40x50x
P/E ratio
Name/Symbol
02170HKBASECARE-B
-1.74x27.29%HK$348.75M
00876HKKAISA HEALTH
-1.73x--HK$170.99M
02393HKYESTAR HEALTH
-1.64x--HK$158.55M
01134HKKELFRED
-5.14x--HK$115.00M
08622HKJOYZYME GROUP
-17.07x--HK$97.94M
08513HKMAXWIN INT HLDG
-9.65x--HK$23.74M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.